Transjugular Intrahepatic Portosystemic Shunt Placement for Variceal Bleeding: Predictors of Mortality

• Published in: Journal of vascular and interventional radiology Vol. 6; no. 5; pp. 687 - 694
• Main Authors: Encarnacion, Carlos E., Palmaz, Julio C., Rivera, Frank J., Alvarez, Oscar A., Chintapalli, Kedar N., Lutz, James D., Reuter, Stewart R.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.09.1995
• Subjects: Adult; Aged; Aged, 80 and over; Esophageal and Gastric Varices - mortality; Esophageal and Gastric Varices - surgery; Esophagus, varices, 71.75; Female; Follow-Up Studies; Gastrointestinal Hemorrhage - mortality; Gastrointestinal Hemorrhage - surgery; Hemorrhoids - mortality; Hemorrhoids - surgery; Humans; Hypertension, portal, 957.711; Male; Middle Aged; Portasystemic Shunt, Surgical - methods; Shunts, portosystemic, 957.453; Stomach, varices, 72.75; Survival Analysis; Hypertension, portal, 957.711; Esophagus, varices, 71.75; Stomach, varices, 72.75; Shunts, portosystemic, 957.453; TIPS
• ISSN: 1051-0443; 1535-7732
• DOI: 10.1016/S1051-0443(95)71165-4

To identify factors that predict survival in patients with variceal bleeding who have undergone transjugular intrahepatic portosystemic shunt (TIPS) placement. TIPS was performed in 64 of 65 patients. Indications were bleeding esophagogastric varices in 64 patients and hemorrhoidal bleeding in one. Child-Pugh classifications were A in two patients, B in 32, and C in 31. Acute bleeding was controlled before TIPS in 26 patients in stable condition but not in 39 patients whose condition was unstable. Twelve patients died within 30 days of TIPS, and another 14 died thereafter. The cumulative survival rate was 67% at 6 months and 56% at 1 year. Cumulative 30-day survival was 96% for stable and 69% for unstable patients, a significant difference ( P = .0135). Thirty-day survival was 91% for patients in Child-Pugh classes A and B combined and 71% for patients in class C ( P = .042). Efforts to control acute bleeding and improve a patient's metabolic status before TIPS are likely to improve 30-day survival.